Giacomo Mazzoli

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

G. Curigliano, M. Fakih, M. Overman, 2022, Journal for ImmunoTherapy of Cancer.

Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer.

M. Fakih, M. Overman, S. Lonardi, 2022, European journal of cancer.

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer

M. Fakih, R. Miceli, M. Overman, 2023, Journal for ImmunoTherapy of Cancer.

Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.

G. Fontanini, N. Zaffaroni, R. Danesi, 2022, JCO precision oncology.

Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors.

M. Fassan, R. Miceli, M. Germani, 2023, European journal of cancer.